期刊文献+

口服胺碘酮致甲状腺功能异常的临床观察 被引量:2

Adverse Drug Reactions from Oral Amiodarone on Thyroid Function
下载PDF
导出
摘要 目的探讨口服胺碘酮对心律失常患者甲状腺功能的影响。方法选取心律失常患者97例,给予口服胺碘酮,第1周200 mg,3次/日;第2周200 mg,2次/日;3周后200 mg,1次/日维持。分别在用药前、用药后7、30、90、180、360天测患者血清甲状腺激素水平。结果共计94例患者完成实验,服用胺碘酮后第7天时,TT3、FT3较治疗前下降,第30天至第90天时,降到最低,与治疗前比较,差异有统计学意义(P<0.05)。TSH在服用胺碘酮后第7天时上升,第30天时达高峰,与治疗前比较,差异有统计学意义(P<0.05)。TT4、FT4于服用胺碘酮第7天时上升,第90天至第180天时达高峰,与治疗前比较,差异有统计学意义(P<0.05)。发生甲状腺功能异常者共22例,占完成实验患者总数的23.4%,其中甲状腺功能减低者20例,甲状腺功能亢进者2例,给予相应处理后,甲状腺激素水平均恢复正常。结论心律失常患者服用胺碘酮,甲状腺激素水平变化显著,甲状腺功能异常者发生率较高,所以用药过程中应定期监测患者甲状腺激素水平的变化,发现异常,及时处理,一般预后良好。 Objective To study the effects of oral amiodarone on thyroid function. Methods 97 patients with cardiac arrhythmias were treated with a loading dose of amiodarone (600 mg/d ) for 1 week and then given with a dose of 400 mg/d for the second week and then with a maintaining dose of 200 mg daily. The serum thyroid hormone levels were detected with radioimmunoassay. Results The serum free and total T3 levels were found to decrease progressively from the 7 th day and significantly at the 1st to 3 rd month. TSH, free and total T4 levels were found to increase at the early stage. The increments reached the peak values at the 1st month for TSH and between the 3rd and 6 th month for free and total T4. 22 cases were found to have abnormal changes in thyroid hormones throughout the study. However, some patients could recover spontaneously but gradually without any therapy, except 9 cases with obvious symptoms. Conclusion The low oral dose of aminod- arone can change the levels of thyroid hormones of the patients with cardiac arrhythmias. However, it recover spontaneously but gradually in most of the cases. Therefore, oral low dose amiodarone is safe for the patients, but they must be monitored closely.
出处 《现代医院》 2017年第1期106-108,共3页 Modern Hospitals
关键词 胺碘酮 甲状腺功能减低 甲状腺功能亢进 Amiodarone Amiodarone - induced hypothyroidism Amiodarone - induced thyrotoxicosis
  • 相关文献

参考文献4

二级参考文献65

  • 1邬月琴,何岚,刘萍,徐莉.碘与自身免疫性甲状腺疾病发病的关系[J].西安交通大学学报(医学版),2006,27(3):295-297. 被引量:14
  • 2Singh BN.Amiodarone as paradigm for developing new drugs for atrial fibrillation[J].J Cardiovasc Pharmacol,2008,52(4):300-305. 被引量:1
  • 3Rabkin SW.Effect of amiodarone on phospholipid content and composition in heart,lung,kidney and skeletal muscle:relationship to alteration in thyroid function[J].Pharmacology,2006,76(3):129-135. 被引量:1
  • 4Rao RH,McReady VR,Spathis GS.Iodine kinetic studies during amiodarone treatment[J].J Clini Endocrinol Metabol,1986,62(3):563-567. 被引量:1
  • 5Yamazaki K,Mitsubashi T,Yamada E,et al.Amiodarone reversibly decreases sodium-iodide symporter mRNA expression at,therapeutic concentrations and induces antioxidant responses at supraphysiological concentrations in cultured human thyroid follicles[J].Thyroid,2007,17(12):1189-1200. 被引量:1
  • 6Newman CM,Price A,Davies DW,et al.Amiodarone and the thyroid:a practical guide to the management of thyroid dysfunction induced by amiodarone therapy[J].Heart,1998,79(2):121-127. 被引量:1
  • 7Schenck JB,Rizvi AA,Lin T.Severe primary hypothyroidism manifesting with torsades de pointes[J].Am J Med Sci,2006,331(3):154-156. 被引量:1
  • 8Hofmann A,Nawara C,Ofluoglu S,et al.Incidence and predictability of amiodarone-induced thyrotoxicosis and hypothyroidism[J].Wien Klin Wochenschr,2008,120(15/16):493-498. 被引量:1
  • 9Basaria S,Cooper DS.Amiodarone and the thyroid[J].Am J Med,2005,118(7):706-714. 被引量:1
  • 10Tedelind S,Larsson F,Johanson C,et al.Amiodarone inhibits thyroidal iodide transport in vitro by a cyclic adenosine 51-monophosphate and iodine-independent mechanism[J].Endocrinology,2006,147(6):2936-2943. 被引量:1

共引文献24

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部